Sign up
Pharma Capital
EPIC: N4P
Market: AIM
52-week High/Low: 28.43p / 2.70p
Sector: Pharma & Biotech
Market Cap: 3.50M
Website: www.n4pharma.com

N4 Pharma was formed in 2014 by Nigel Theobald, the former chief executive of AIM-quoted Oxford Pharmascience Group PLC. N4 Pharma is a specialist pharmaceutical company that reformulates existing drugs and vaccines to improve their performance.

N4 Pharma’s reformulation work falls under two divisions:

1.generic, already commercialised, drugs; and
2.delivery of novel and existing...

N4 Pharma PLC

www.n4pharma.com

Interactive graph

col 3
col 4
col 5
col 6
View full N4P profile View Profile
View All

Market Reports Including N4P

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.